Congratulations to Prof. Dor Salomon on becoming Full Professor!

Prof. Salomon, PhD, is at the Department of Clinical Microbiology and Immunology at the School of Medicine. He completed his PhD (direct track) at Tel Aviv University, followed by a Postdoctoral fellowship at the University of Texas Southwestern Medical Center.  Prof. Salomon was awarded the NIH Pathway to Independence Award (K99/R00) and was also awarded the Alon Fellowship for young investigators and the prestigious European Research Council (ERC) Starting and Consolidator grants. During the period of the COVID-19 quarantine, he pioneered the organization of virtual international conferences. Prof. Salomon is an elected board member of the Israel Society for Microbiology. He is also a member of the international Vibrio organizing committee, in charge of the bi-annual meetings of Vibrio researchers from around the world. 

Prof. Salomon works on bacterial toxins and antibacterial treatments. The World Health Organization predicts that by 2050, multidrug-resistant pathogens will become the leading cause of death worldwide. To prevent this catastrophe, the development of novel antibacterial treatments is necessary. Prof. Salomon is employing multi-disciplinary approaches to study mechanisms and toxins that are used by bacteria to neutralize their bacterial competitors. By adapting and custom-engineering these natural antibacterial mechanisms, Prof. Salomon is developing next-generation antibacterial treatments and prophylactics. In addition, Prof. Salomon’s research focuses on identifying and investigating virulence toxins used by bacteria to colonize animal hosts and cause disease.

More information at: dorsalomonlab.sites.tau.ac.il